T. Rowe Price Associates, Inc. 13D and 13G filings for Pliant Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 1:22 pm Purchase | 2024-09-30 | 13G | Pliant Therapeutics, Inc. PLRX | T. Rowe Price Associates, Inc. | 4,834,813 8.000% | 1,046,697 (+27.63%) | Filing |
| 2024-02-14 10:03 am Purchase | 2023-12-31 | 13G | Pliant Therapeutics, Inc. PLRX | T. Rowe Price Associates, Inc. | 3,788,116 6.300% | 3,788,116 (New Position) | Filing |